Participant event and timeline
| Timepoint (post last dose) | Phase 1 | Phase 2 | ||||
| 2–6 weeks | 1 month | 3 months | 6 months | 9 months | 12 months | |
| Eligibility screening | x | x | x | x | x | x |
| Allocation | x | x | x | x | x | x |
| Informed consent | x | x | x | x | x | x |
| Sociodemographic data | x | |||||
| COVID-19 vaccination history | x | x | x | x | x | x |
| Medical history | x | |||||
| Drug history | x | |||||
| Blood samples | x | x | x | x | x | x |
| COVID-19 breakthrough infection history | x | x | x | x | x | x |